Brief: Pivot Pharma Announces C$15 Million Private Placement And Partnership
09/04/2019 17:49
April 9 (Reuters) - Pivot Pharmaceuticals Inc PVOT.CD :
* PIVOT PHARMA ANNOUNCES C$15 MILLION PRIVATE PLACEMENT AND
STRATEGIC PARTNERSHIP
* PRIVATE PLACEMENT WILL BE OF UNITS AT A PRICE OF $0.25 PER
UNIT
* UPON COMPLETION JOE MIMRAN, CHAIRMAN OF HIGH PARK VENTURES
WILL
JOIN CO'S ADVISORY COMMITTEE
* SIGNED A BINDING LETTER OF INTENT, DATED APRIL 8, 2019,
WITH
HIGH PARK VENTURES FOR NON-BROKERED PRIVATE PLACEMENT OF $15
MILLION
Source text for Eikon: ID:nCNWDwcJva
Further company coverage: PVOT.CD
((Reuters.Briefs@thomsonreuters.com;))
Recent news on BetterLife Pharma
See all newsBrief: Betterlife Pharma Provides Scientific Update On Neuroplastogenic Activity Of BETR-001
Brief: Betterlife Pharma Advanced In IND-enabling Studies For BETR-001
Brief: BetterLife Announces Closing Of $1.168 Million Convertible Debentures To Further Advance IND-Enabling Studies Of Its Non-Hallucinogenic LSD-Based Drug Candidate BETR-001
Brief: Omineca Announces $2 Mln Brokered Financing Of Flow-Through Units
Brief: Betterlife Announces Pricing Of Proposed Offering Of Units